In many carcinomas (e.g., liver carcinoma [32], lung carcinoma [33] and colorectal carcinoma [34]), ZFP36L1 represses oncogenic protein expression and tumor progression, whereas in gastric carcinoma [35], ZFP36L1 promotes tumor progression. Here, ZFP36L1 is linked to lung carcinoma.